EFG Asset Management’s Cytokinetics CYTK Stock Holding History

EFG Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$4.01M	Sell	73,010 -3,247	-4%	-$134K	0.52%	82
2025 Q2	$2.52M	Sell	76,257 -4,102	-5%	-$143K	0.36%	123
2025 Q1	$3.23M	Sell	80,359 -3,503	-4%	-$161K	0.54%	63
2024 Q4	$3.94M	Buy	83,862 +49,628	+145%	+$2.58M	0.54%	62
2024 Q3	$1.81M	Buy	34,234 +2,468	+8%	+$138K	0.3%	147
2024 Q2	$1.72M	Buy	31,766 +150	+0.5%	+$9.05K	0.3%	134
2024 Q1	$2.22M	Sell	31,616 -602	-2%	-$46.6K	0.38%	105
2023 Q4	$2.69M	Sell	32,218 -3,485	-10%	-$126K	0.51%	72
2023 Q3	$1.05M	Sell	35,703 -3,409	-9%	-$114K	0.25%	139
2023 Q2	$1.28M	Sell	39,112 -2,314	-6%	-$85.6K	0.27%	125
2023 Q1	$1.46M	Sell	41,426 -2,320	-5%	-$94.6K	0.32%	110
2022 Q4	$2M	Buy	43,746 +12,897	+42%	+$555K	0.45%	77
2022 Q3	$1.49M	Sell	30,849 -2,321	-7%	-$112K	0.35%	105
2022 Q2	$1.3M	Sell	33,170 -2,846	-8%	-$115K	0.27%	116
2022 Q1	$1.33M	Sell	36,016 -471	-1%	-$16.7K	0.2%	148
2021 Q4	$1.66M	Buy	+36,487	New	+$1.41M	0.22%	134

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

EFG Asset Management's CYTK Position: Q3 2025 in Review

EFG Asset Management reduced its Cytokinetics (CYTK) stake by 4.3% in Q3 2025, selling an estimated $134K and leaving 73,010 shares worth $4.01M. The position accounts for 0.52% of the portfolio, ranked #82.

EFG Asset Management first reported a position in CYTK in Q4 2021 and has held it in 16 quarters since. 380 funds tracked by Wall St. Rank hold CYTK as of Q3 2025.

EFG Asset Management held 73,010 shares of Cytokinetics worth $4.01M as of Q3 2025.
EFG Asset Management sold 3,247 Cytokinetics shares in Q3 2025, an estimated $134K.
Cytokinetics made up 0.52% of EFG Asset Management's portfolio in Q3 2025, its #82 holding.
EFG Asset Management first reported a position in Cytokinetics in Q4 2021 and has held it in 16 quarters since.
380 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2025.

Based on EFG Asset Management's 13F filing for Q3 2025, filed 3 Nov 2025.